# Intravenous Treatment of Anemia in Pregnancy

> **NCT03317210** · PHASE4 · COMPLETED · sponsor: **University of Zurich** · enrollment: 50 (actual)

## Conditions studied

- Anemia

## Interventions

- **DRUG:** iron sucrose (200 mg VENOFER®)
- **DRUG:** recombinant human erythropoietin (10,000 U EPREX®)

## Key facts

- **NCT ID:** NCT03317210
- **Lead sponsor:** University of Zurich
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09-01
- **Primary completion:** 2006-07-31
- **Final completion:** 2006-07-31
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2017-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03317210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03317210, "Intravenous Treatment of Anemia in Pregnancy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03317210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*